Cancer stem cells (CSCs), known also as tumor-initiating cells, are quiescent, pluripotent,
self-renewing neoplastic cells that were first identified in hematologic tumors and soon after …

IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an
innovative method to produce antibodies for therapy and prophylaxis. Advantages of IgY …

Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the
19th century, their potential for use as biotechnological reagents has been exploited in …

Biomarkers for resistance in Glioblastoma multiforme (GBM) are lacking, and progress in the
clinic has been slow to arrive. CD133 (prominin-1) is a membrane-bound glycoprotein on …

Glioblastoma (GBM) is the most common primary malignant brain tumor with a high mortality
rate. The current treatment consists of surgical resection, radiation, and chemotherapy; …

Cancer stem cells (CSCs) are self-renewing multipotent cells that play a vital role in the
development of cancer drug resistance conditions. Various therapies like conventional …

Due to their high specificity and scalability, Monoclonal IgY antibodies have emerged as a
valuable alternative to traditional polyclonal IgY antibodies. This abstract provides an …

Cancer stem cells (CSCs), known also as tumor-initiating cells, are quiescent, pluripotent,
self-renewing neoplastic cells that were first identified in hematologic tumors and soon after …

Hens produce a class of antibodies called IgY whose natural role is to protect the chicken
and the growing chick inside the egg. The overall structure of the IgY molecule is similar to …

Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the
19th century, their potential for use as biotechnological reagents has been exploited in …